The schizophrenia-associated gene CSMD1 encodes a complement classical pathway inhibitor predominantly expressed by astrocytes and at synapses in mice and humans
Robert A.J. Byrne(Cardiff University), B. Paul Morgan(UK Dementia Research Institute)
Cited by 11
Related Papers
Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models
|Acta Neuropathologica Communications|2022|97
Faculty Opinions recommendation of Cardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2019|0
Faculty Opinions recommendation of Nitrosative stress drives heart failure with preserved ejection fraction.
|Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature|2019|0